Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Scalp Cooling in MBC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial from Dana-Farber Cancer Institute evaluating scalp cooling to prevent chemotherapy-induced alopecia in patients with metastatic breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Breast Cancer, Chemotherapy-induced Alopecia | Phase 2 | Status: RECRUITING